Granules India is recalling over 33,000 bottles of Metoprolol Succinate, a generic blood pressure medication, in the US due to manufacturing issues. The USFDA reported that the India-produced lot failed to meet dissolution specifications during stability studies. This Class II recall, initiated on June 24, indicates a potential for temporary or medically reversible health consequences.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aPLj7Zr
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Granules India recalls 33,000 bottles of blood lowering medication in US
0 comments:
Post a Comment